Also looking at clause 5, where what we're doing is we're actually broadening the definition of a screening test to include things like high-risk HPV testing and also cervical or vaginal cytology. So just really thinking through the impact that will have in terms of futureproofing the screening programme so that we can have and use those more up-to-date tests and looking at what that will do in terms of making sure that we can follow up those who are late for their smear tests, and secondly thinking through how we have reductions in inequalities in terms of cervical screening. So just talking through those points. Thank you, Madam Chair.